Teva’s ‘Skinny Label’ Dispute Edges Toward Supreme Court With Government’s Backing

 
• By Brenda Sandburg
  
Skinny label
US goverment sides with Teva in skinny label patent dispute with GlaxoSmithKline • Source: Shutterstock

More from Generics

More from Biosimilars & Generics